Exact Sciences Corporation develops cancer screening and diagnostic products worldwide, notably including the Cologuard and Oncotype DX tests. Alongside their current offerings, they are developing pipeline products to enhance existing tests while exploring new blood and fluid-based options. Founded in 1995 and based in Madison, Wisconsin, the company has an ongoing agreement with the MAYO Foundation for Medical Education and Research, as well as current Covid-19 testing services.